Drugs / Joins
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04718649 | Jan 2021 → Dec 2022 | osteoarthritis | The Catholic University of Korea | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06204952 Comparator | Jun 2024 → Jan 2026 | arthropathy | Jeeyoun Moon | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Joins | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06204952 ↗ |
| Route | Oral | “Test Group: Administer Joins® 200 mg orally three times a day” NCT06204952 ↗ |